149 related articles for article (PubMed ID: 26032198)
1. Bongkrekic acid analogue, lacking one of the carboxylic groups of its parent compound, shows moderate but pH-insensitive inhibitory effects on the mitochondrial ADP/ATP carrier.
Yamamoto A; Hasui K; Matsuo H; Okuda K; Abe M; Matsumoto K; Harada K; Yoshimura Y; Yamamoto T; Ohkura K; Shindo M; Shinohara Y
Chem Biol Drug Des; 2015 Nov; 86(5):1304-22. PubMed ID: 26032198
[TBL] [Abstract][Full Text] [Related]
2. KH-17, a simplified derivative of bongkrekic acid, weakly inhibits the mitochondrial ADP/ATP carrier from both sides of the inner mitochondrial membrane.
Takegawa K; Ito T; Yamamoto A; Yamazaki N; Shindo M; Shinohara Y
Chem Biol Drug Des; 2023 Apr; 101(4):865-872. PubMed ID: 36527173
[TBL] [Abstract][Full Text] [Related]
3. Isobongkrekic acid, a new inhibitor of mitochondrial ADP-ATP transport: radioactive labeling and chemical and biological properties.
Lauquin GJ; Duplaa AM; Klein G; Rousseau A; Vignais PV
Biochemistry; 1976 Jun; 15(11):2323-7. PubMed ID: 1276139
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the ADP/ATP carrier in calcium-induced perturbations of the mitochondrial inner membrane permeability: importance of the orientation of the nucleotide binding site.
Lê Quôc K; Lê Quôc D
Arch Biochem Biophys; 1988 Sep; 265(2):249-57. PubMed ID: 2844116
[TBL] [Abstract][Full Text] [Related]
5. The ADP and ATP transport in mitochondria and its carrier.
Klingenberg M
Biochim Biophys Acta; 2008 Oct; 1778(10):1978-2021. PubMed ID: 18510943
[TBL] [Abstract][Full Text] [Related]
6. Identification of new highly selective inhibitors of the human ADP/ATP carriers by molecular docking and in vitro transport assays.
Todisco S; Di Noia MA; Onofrio A; Parisi G; Punzi G; Redavid G; De Grassi A; Pierri CL
Biochem Pharmacol; 2016 Jan; 100():112-32. PubMed ID: 26616220
[TBL] [Abstract][Full Text] [Related]
7. Substrate-site interactions in the membrane-bound adenine-nucleotide carrier as disclosed by ADP and ATP analogs.
Block MR; Vignais PV
Biochim Biophys Acta; 1984 Nov; 767(2):369-76. PubMed ID: 6093873
[TBL] [Abstract][Full Text] [Related]
8. Conformation-dependent swinging of the matrix loop m2 of the mitochondrial Saccharomyces cerevisiae ADP/ATP carrier.
Dahout-Gonzalez C; Ramus C; Dassa EP; Dianoux AC; Brandolin G
Biochemistry; 2005 Dec; 44(49):16310-20. PubMed ID: 16331992
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and physical parameters of the electrical currents measured with the ADP/ATP carrier by photolysis of caged ADP and ATP.
Broustovetsky N; Bamberg E; Gropp T; Klingenberg M
Biochemistry; 1997 Nov; 36(45):13865-72. PubMed ID: 9374864
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of Mg2+ from rat heart and liver mitochondria following the interaction of thyroid hormone with the adenine nucleotide translocase.
Romani A; Marfella C; Lakshmanan M
Thyroid; 1996 Oct; 6(5):513-9. PubMed ID: 8936681
[TBL] [Abstract][Full Text] [Related]
11. Bongkrekic Acid-a Review of a Lesser-Known Mitochondrial Toxin.
Anwar M; Kasper A; Steck AR; Schier JG
J Med Toxicol; 2017 Jun; 13(2):173-179. PubMed ID: 28105575
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of electrical activity in mouse pancreatic beta-cells by the ATP/ADP translocase inhibitor, bongkrekic acid.
Kiranadi B; Bangham JA; Smith PA
FEBS Lett; 1991 May; 283(1):93-6. PubMed ID: 2037079
[TBL] [Abstract][Full Text] [Related]
13. Binding of nucleotides by the mitochondrial ADP/ATP carrier as studied by 1H nuclear magnetic resonance spectroscopy.
Huber T; Klingenberg M; Beyer K
Biochemistry; 1999 Jan; 38(2):762-9. PubMed ID: 9888816
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum: functional mitochondrial ADP/ATP transporter in Escherichia coli plasmic membrane as a tool for selective drug screening.
Razakantoanina V; Florent I; Jaureguiberry G
Exp Parasitol; 2008 Feb; 118(2):181-7. PubMed ID: 17920591
[TBL] [Abstract][Full Text] [Related]
15. Reversed activity of mitochondrial adenine nucleotide translocator in ischemia-reperfusion.
Belous A; Knox C; Nicoud IB; Pierce J; Anderson C; Pinson CW; Chari RS
Transplantation; 2003 May; 75(10):1717-23. PubMed ID: 12777862
[TBL] [Abstract][Full Text] [Related]
16. Molecular design, synthesis, and evaluation of novel potent apoptosis inhibitors inspired from bongkrekic acid.
Okuda K; Hasui K; Abe M; Matsumoto K; Shindo M
Chem Res Toxicol; 2012 Oct; 25(10):2253-60. PubMed ID: 22998163
[TBL] [Abstract][Full Text] [Related]
17. The transport mechanism of the mitochondrial ADP/ATP carrier.
Kunji ER; Aleksandrova A; King MS; Majd H; Ashton VL; Cerson E; Springett R; Kibalchenko M; Tavoulari S; Crichton PG; Ruprecht JJ
Biochim Biophys Acta; 2016 Oct; 1863(10):2379-93. PubMed ID: 27001633
[TBL] [Abstract][Full Text] [Related]
18. Electrical currents associated with nucleotide transport by the reconstituted mitochondrial ADP/ATP carrier.
Brustovetsky N; Becker A; Klingenberg M; Bamberg E
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):664-8. PubMed ID: 8570612
[TBL] [Abstract][Full Text] [Related]
19. Adenine nucleotide transport in sonic submitochondrial particles. Kinetic properties and binding of specific inhibitors.
Lauquin GJ; Villiers C; Michejda JW; Hryniewiecka LV; Vignais PV
Biochim Biophys Acta; 1977 May; 460(2):331-45. PubMed ID: 15594
[TBL] [Abstract][Full Text] [Related]
20. Four mutations in transmembrane domains of the mitochondrial ADP/ATP carrier increase resistance to bongkrekic acid.
Zeman I; Schwimmer C; Postis V; Brandolin G; David C; Trézéguet V; Lauquin GJ
J Bioenerg Biomembr; 2003 Jun; 35(3):243-56. PubMed ID: 13678275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
